415 related articles for article (PubMed ID: 23471552)
1. Identification and characterization of Wnt signaling pathway in keloid pathogenesis.
Igota S; Tosa M; Murakami M; Egawa S; Shimizu H; Hyakusoku H; Ghazizadeh M
Int J Med Sci; 2013; 10(4):344-54. PubMed ID: 23471552
[TBL] [Abstract][Full Text] [Related]
2. The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells.
Yuan Y; Niu CC; Deng G; Li ZQ; Pan J; Zhao C; Yang ZL; Si WK
Int J Mol Med; 2011 Jan; 27(1):63-9. PubMed ID: 21069266
[TBL] [Abstract][Full Text] [Related]
3. Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context.
Mikels AJ; Nusse R
PLoS Biol; 2006 Apr; 4(4):e115. PubMed ID: 16602827
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of Ror2 and Wnt5a expression in medulloblastoma.
Lee SE; Lim SD; Kang SY; Suh SB; Suh YL
Brain Pathol; 2013 Jul; 23(4):445-53. PubMed ID: 23278988
[TBL] [Abstract][Full Text] [Related]
5. Wnt5a mediated canonical Wnt signaling pathway activation in orthodontic tooth movement: possible role in the tension force-induced bone formation.
Fu HD; Wang BK; Wan ZQ; Lin H; Chang ML; Han GL
J Mol Histol; 2016 Oct; 47(5):455-66. PubMed ID: 27456852
[TBL] [Abstract][Full Text] [Related]
6. CD82 inhibits canonical Wnt signalling by controlling the cellular distribution of β-catenin in carcinoma cells.
Chigita S; Sugiura T; Abe M; Kobayashi Y; Shimoda M; Onoda M; Shirasuna K
Int J Oncol; 2012 Dec; 41(6):2021-8. PubMed ID: 23076981
[TBL] [Abstract][Full Text] [Related]
7. Hear the Wnt Ror: how melanoma cells adjust to changes in Wnt.
O'Connell MP; Weeraratna AT
Pigment Cell Melanoma Res; 2009 Dec; 22(6):724-39. PubMed ID: 19708915
[TBL] [Abstract][Full Text] [Related]
8. Immunocytochemical Analysis of Endogenous Frizzled-(Co-)Receptor Interactions and Rapid Wnt Pathway Activation in Mammalian Cells.
Neuhaus J; Weimann A; Berndt-Paetz M
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769487
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic identification of receptor tyrosine kinase-like orphan receptor 2 as a functional tumor suppressor inhibiting β-catenin and AKT signaling but frequently methylated in common carcinomas.
Li L; Ying J; Tong X; Zhong L; Su X; Xiang T; Shu X; Rong R; Xiong L; Li H; Chan AT; Ambinder RF; Guo Y; Tao Q
Cell Mol Life Sci; 2014 Jun; 71(11):2179-92. PubMed ID: 24158497
[TBL] [Abstract][Full Text] [Related]
10. Wnt5a modulates glycogen synthase kinase 3 to induce phosphorylation of receptor tyrosine kinase Ror2.
Yamamoto H; Yoo SK; Nishita M; Kikuchi A; Minami Y
Genes Cells; 2007 Nov; 12(11):1215-23. PubMed ID: 17986005
[TBL] [Abstract][Full Text] [Related]
11. Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis.
Geng M; Cao YC; Chen YJ; Jiang H; Bi LQ; Liu XH
World J Gastroenterol; 2012 Mar; 18(12):1328-38. PubMed ID: 22493546
[TBL] [Abstract][Full Text] [Related]
12. Decoy Wnt receptor (sLRP6E1E2)-expressing adenovirus induces anti-fibrotic effect via inhibition of Wnt and TGF-β signaling.
Lee WJ; Lee JS; Ahn HM; Na Y; Yang CE; Lee JH; Hong J; Yun CO
Sci Rep; 2017 Nov; 7(1):15070. PubMed ID: 29118355
[TBL] [Abstract][Full Text] [Related]
13. WNT5A: a double-edged sword in colorectal cancer progression.
Tufail M; Wu C
Mutat Res Rev Mutat Res; 2023; 792():108465. PubMed ID: 37495091
[TBL] [Abstract][Full Text] [Related]
14. Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis.
Maeda K; Kobayashi Y; Udagawa N; Uehara S; Ishihara A; Mizoguchi T; Kikuchi Y; Takada I; Kato S; Kani S; Nishita M; Marumo K; Martin TJ; Minami Y; Takahashi N
Nat Med; 2012 Feb; 18(3):405-12. PubMed ID: 22344299
[TBL] [Abstract][Full Text] [Related]
15. Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells.
Bolzoni M; Donofrio G; Storti P; Guasco D; Toscani D; Lazzaretti M; Bonomini S; Agnelli L; Capocefalo A; Dalla Palma B; Neri A; Nicolini F; Lisignoli G; Russo F; Colla S; Aversa F; Giuliani N
Leukemia; 2013 Feb; 27(2):451-63. PubMed ID: 22781592
[TBL] [Abstract][Full Text] [Related]
16. Reduced Frizzled Receptor 4 Expression Prevents WNT/β-Catenin-driven Alveolar Lung Repair in Chronic Obstructive Pulmonary Disease.
Skronska-Wasek W; Mutze K; Baarsma HA; Bracke KR; Alsafadi HN; Lehmann M; Costa R; Stornaiuolo M; Novellino E; Brusselle GG; Wagner DE; Yildirim AÖ; Königshoff M
Am J Respir Crit Care Med; 2017 Jul; 196(2):172-185. PubMed ID: 28245136
[TBL] [Abstract][Full Text] [Related]
17. The Meckel-Gruber syndrome protein TMEM67 controls basal body positioning and epithelial branching morphogenesis in mice via the non-canonical Wnt pathway.
Abdelhamed ZA; Natarajan S; Wheway G; Inglehearn CF; Toomes C; Johnson CA; Jagger DJ
Dis Model Mech; 2015 Jun; 8(6):527-41. PubMed ID: 26035863
[TBL] [Abstract][Full Text] [Related]
18. Stable genetic alterations of β-catenin and ROR2 regulate the Wnt pathway, affect the fate of MSCs.
Cai SX; Liu AR; He HL; Chen QH; Yang Y; Guo FM; Huang YZ; Liu L; Qiu HB
J Cell Physiol; 2014 Jun; 229(6):791-800. PubMed ID: 24590964
[TBL] [Abstract][Full Text] [Related]
19. Anti-apoptotic action of Wnt5a in dermal fibroblasts is mediated by the PKA signaling pathways.
Torii K; Nishizawa K; Kawasaki A; Yamashita Y; Katada M; Ito M; Nishimoto I; Terashita K; Aiso S; Matsuoka M
Cell Signal; 2008 Jul; 20(7):1256-66. PubMed ID: 18407462
[TBL] [Abstract][Full Text] [Related]
20. Canonical and non-canonical Wnt signaling are simultaneously activated by Wnts in colon cancer cells.
Flores-Hernández E; Velázquez DM; Castañeda-Patlán MC; Fuentes-García G; Fonseca-Camarillo G; Yamamoto-Furusho JK; Romero-Avila MT; García-Sáinz JA; Robles-Flores M
Cell Signal; 2020 Aug; 72():109636. PubMed ID: 32283254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
